Exploratory analysis of retreatment with brentuximab vedotin (BV) after frontline treatment with brentuximab vedotin and CHP (A+CHP) for patients (pts) with CD30+ peripheral T-cell lymphoma (ECHELON-2) Meeting Abstract
| Authors: | Trümper, L.; Pro, B.; Horwitz, S.; O'connor, O.; Tilly, H.; Choi, I.; Gritti, G.; Fox, C.; Alpdogan, O.; Mayer, J.; Briones, J.; Jacobsen, E.; Pezzutto, A.; Demeter, J.; Gurion, R.; Jurczak, W.; Kuo, C. Y.; Opat, S.; Little, M.; Brown, L.; Puhlmann, M.; Illidge, T. |
| Abstract Title: | Exploratory analysis of retreatment with brentuximab vedotin (BV) after frontline treatment with brentuximab vedotin and CHP (A+CHP) for patients (pts) with CD30+ peripheral T-cell lymphoma (ECHELON-2) |
| Meeting Title: | 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 9-11 |
| Meeting Location: | Virtual |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-10-01 |
| Start Page: | 119 |
| Language: | English |
| ACCESSION: | WOS:000575955000275 |
| PROVIDER: | wos |
| DOI: | 10.1159/000510995 |
| Notes: | Meeting Abstract: 507 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos |
